Skip to main content
. 2013 Mar 9;381(9869):805–816. doi: 10.1016/S0140-6736(12)61963-1

Figure 2.

Figure 2

Treatment compliance (A) and proportion of patients in follow-up (B) by year since randomisation for 6846 women with ER-positive disease (54% node-negative)

*>99% tamoxifen.